Search

Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients

4.5 (369) · $ 15.99 · In stock

Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer  patients
IJMS, Free Full-Text

IJMS, Free Full-Text

Association between pertuzumab-associated diarrhoea and rash and

Association between pertuzumab-associated diarrhoea and rash and

Subcutaneous Pertuzumab/Trastuzumab Combo Continues to Prove Safe

Subcutaneous Pertuzumab/Trastuzumab Combo Continues to Prove Safe

HER2-Positive Metastatic Breast Cancer Patients Receiving

HER2-Positive Metastatic Breast Cancer Patients Receiving

Skin Lesions in Patient With Metastatic Breast Cancer

Skin Lesions in Patient With Metastatic Breast Cancer

PDF) Pruritus related to trastuzumab and pertuzumab in HER2 +

PDF) Pruritus related to trastuzumab and pertuzumab in HER2 +

1969-Breast neoadjuvant DOCEtaxel, pERTUZumab and trastuzumab

1969-Breast neoadjuvant DOCEtaxel, pERTUZumab and trastuzumab

PDF) The European Medicines Agency Review of Pertuzumab for the

PDF) The European Medicines Agency Review of Pertuzumab for the

Pruritus related to trastuzumab and pertuzumab in HER2 + breast

Pruritus related to trastuzumab and pertuzumab in HER2 + breast